nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—Captodiame—DRD3—attention deficit hyperactivity disorder	0.00919	0.349	CrCbGaD
Brompheniramine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00758	0.0431	CbGeAlD
Brompheniramine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00749	0.0426	CbGeAlD
Brompheniramine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.0073	0.0415	CbGeAlD
Brompheniramine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00682	0.0387	CbGeAlD
Brompheniramine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00633	0.036	CbGeAlD
Brompheniramine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.0061	0.0347	CbGeAlD
Brompheniramine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00592	0.0337	CbGeAlD
Brompheniramine—CHRM4—brain—attention deficit hyperactivity disorder	0.00579	0.0329	CbGeAlD
Brompheniramine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00576	0.0328	CbGeAlD
Brompheniramine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.0057	0.0324	CbGeAlD
Brompheniramine—KCNH2—forebrain—attention deficit hyperactivity disorder	0.00541	0.0307	CbGeAlD
Brompheniramine—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.00457	0.026	CbGeAlD
Brompheniramine—CHRM5—brain—attention deficit hyperactivity disorder	0.00453	0.0257	CbGeAlD
Brompheniramine—HRH1—forebrain—attention deficit hyperactivity disorder	0.00434	0.0246	CbGeAlD
Brompheniramine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00407	0.0231	CbGeAlD
Brompheniramine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00391	0.0222	CbGeAlD
Brompheniramine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.00386	0.147	CrCbGaD
Brompheniramine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00375	0.0213	CbGeAlD
Brompheniramine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00372	0.0211	CbGeAlD
Brompheniramine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.0037	0.021	CbGeAlD
Brompheniramine—KCNH2—midbrain—attention deficit hyperactivity disorder	0.00357	0.0203	CbGeAlD
Brompheniramine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00356	0.0202	CbGeAlD
Brompheniramine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00352	0.02	CbGeAlD
Brompheniramine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00331	0.0188	CbGeAlD
Brompheniramine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0033	0.0187	CbGeAlD
Brompheniramine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00319	0.0181	CbGeAlD
Brompheniramine—CHRM2—brain—attention deficit hyperactivity disorder	0.00311	0.0177	CbGeAlD
Brompheniramine—KCNH2—nervous system—attention deficit hyperactivity disorder	0.00294	0.0167	CbGeAlD
Brompheniramine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.00288	0.11	CrCbGaD
Brompheniramine—CHRM1—brain—attention deficit hyperactivity disorder	0.00283	0.0161	CbGeAlD
Brompheniramine—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.00283	0.0161	CbGeAlD
Brompheniramine—Promazine—DRD4—attention deficit hyperactivity disorder	0.00281	0.107	CrCbGaD
Brompheniramine—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.00276	0.0157	CbGeAlD
Brompheniramine—CHRM3—brain—attention deficit hyperactivity disorder	0.00253	0.0144	CbGeAlD
Brompheniramine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00241	0.0137	CbGeAlD
Brompheniramine—Promazine—DRD1—attention deficit hyperactivity disorder	0.00238	0.0905	CrCbGaD
Brompheniramine—HRH1—nervous system—attention deficit hyperactivity disorder	0.00235	0.0134	CbGeAlD
Brompheniramine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00232	0.0132	CbGeAlD
Brompheniramine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.00227	0.0129	CbGeAlD
Brompheniramine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00226	0.0129	CbGeAlD
Brompheniramine—KCNH2—brain—attention deficit hyperactivity disorder	0.00224	0.0128	CbGeAlD
Brompheniramine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.00221	0.0841	CrCbGaD
Brompheniramine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00218	0.0124	CbGeAlD
Brompheniramine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00213	0.0121	CbGeAlD
Brompheniramine—CYP2C8—brain—attention deficit hyperactivity disorder	0.00205	0.0117	CbGeAlD
Brompheniramine—CYP2B6—brain—attention deficit hyperactivity disorder	0.00184	0.0105	CbGeAlD
Brompheniramine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00182	0.0103	CbGeAlD
Brompheniramine—HRH1—brain—attention deficit hyperactivity disorder	0.0018	0.0102	CbGeAlD
Brompheniramine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00179	0.0102	CbGeAlD
Brompheniramine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00175	0.00996	CbGeAlD
Brompheniramine—CYP2E1—brain—attention deficit hyperactivity disorder	0.00173	0.00983	CbGeAlD
Brompheniramine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00172	0.0098	CbGeAlD
Brompheniramine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00169	0.00958	CbGeAlD
Brompheniramine—Promazine—DRD2—attention deficit hyperactivity disorder	0.00168	0.0638	CrCbGaD
Brompheniramine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00137	0.00778	CbGeAlD
Brompheniramine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.0013	0.0493	CrCbGaD
Brompheniramine—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000337	0.000422	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000336	0.000422	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000335	0.00042	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000334	0.000419	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000328	0.000412	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000328	0.000411	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000327	0.00041	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000324	0.000406	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000322	0.000404	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000317	0.000397	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000316	0.000396	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000315	0.000395	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000313	0.000392	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000311	0.00039	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000307	0.000385	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000303	0.00038	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000302	0.000379	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0003	0.000376	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000299	0.000374	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000298	0.000374	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000298	0.000373	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000295	0.00037	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000294	0.000369	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000286	0.000359	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000281	0.000353	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000276	0.000345	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000275	0.000344	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000274	0.000344	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000274	0.000343	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000272	0.000341	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000271	0.00034	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000271	0.00034	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00027	0.000339	CbGpPWpGaD
Brompheniramine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000269	0.000337	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000268	0.000336	CbGpPWpGaD
Brompheniramine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000267	0.000335	CbGpPWpGaD
Brompheniramine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000265	0.000333	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000264	0.000331	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000264	0.00033	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000263	0.000329	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000262	0.000328	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000261	0.000328	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000261	0.000327	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00026	0.000326	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00026	0.000326	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000258	0.000323	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000244	0.000305	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000243	0.000304	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000242	0.000303	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000242	0.000303	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00024	0.0003	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000238	0.000298	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000238	0.000298	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000237	0.000297	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000237	0.000297	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000237	0.000297	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000236	0.000296	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000236	0.000296	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000236	0.000296	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000235	0.000295	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000235	0.000295	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000234	0.000294	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000234	0.000293	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000233	0.000292	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000232	0.000291	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000232	0.000291	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000232	0.000291	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000231	0.00029	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000231	0.00029	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00023	0.000289	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00023	0.000289	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000229	0.000287	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000228	0.000286	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000228	0.000286	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000228	0.000286	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000228	0.000285	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000228	0.000285	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000227	0.000285	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000227	0.000284	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000226	0.000283	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000225	0.000282	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000224	0.000281	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000221	0.000277	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000221	0.000277	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00022	0.000276	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00022	0.000275	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000218	0.000273	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000214	0.000269	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000214	0.000268	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000213	0.000267	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000213	0.000267	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000213	0.000267	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000212	0.000266	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000212	0.000265	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000211	0.000264	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000211	0.000264	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00021	0.000263	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00021	0.000263	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000209	0.000262	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000208	0.000261	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000208	0.00026	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000207	0.00026	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000207	0.00026	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000207	0.000259	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000205	0.000257	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000205	0.000256	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000201	0.000251	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000199	0.000249	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000194	0.000243	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000194	0.000243	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000194	0.000243	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000193	0.000242	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000193	0.000242	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000192	0.000241	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000192	0.000241	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000191	0.000239	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000191	0.000239	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000187	0.000234	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000185	0.000232	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000184	0.00023	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000183	0.000229	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000182	0.000228	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000179	0.000225	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000178	0.000223	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000176	0.000221	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000174	0.000218	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000169	0.000212	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000168	0.000211	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000167	0.000209	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000167	0.000209	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000167	0.000209	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000164	0.000206	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000164	0.000205	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000164	0.000205	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000162	0.000203	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000161	0.000202	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000161	0.000202	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00016	0.000201	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00016	0.0002	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000158	0.000198	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000155	0.000195	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000153	0.000192	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00015	0.000188	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000149	0.000187	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000149	0.000187	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000148	0.000186	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.000185	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000147	0.000184	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000141	0.000177	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000141	0.000177	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000141	0.000176	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00014	0.000176	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00014	0.000175	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000139	0.000174	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000138	0.000173	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000136	0.00017	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000135	0.00017	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000135	0.000169	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000134	0.000167	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000133	0.000167	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000131	0.000164	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000131	0.000164	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00013	0.000163	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00013	0.000163	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000129	0.000162	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000129	0.000161	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.000159	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000127	0.000159	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000126	0.000158	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000126	0.000158	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000126	0.000158	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000126	0.000158	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000125	0.000156	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000125	0.000156	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000124	0.000156	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000124	0.000156	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000124	0.000155	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000124	0.000155	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000123	0.000154	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000122	0.000153	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000122	0.000153	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000122	0.000153	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000121	0.000152	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000118	0.000149	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000118	0.000147	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000117	0.000146	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000116	0.000146	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000116	0.000146	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000115	0.000145	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000115	0.000144	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000115	0.000144	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000114	0.000143	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000114	0.000143	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000114	0.000143	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000114	0.000143	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000113	0.000142	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000113	0.000142	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000113	0.000142	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000113	0.000141	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00011	0.000138	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000108	0.000135	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000106	0.000133	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000105	0.000132	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000101	0.000127	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000101	0.000127	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000101	0.000126	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	9.91e-05	0.000124	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.84e-05	0.000123	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.61e-05	0.00012	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.28e-05	0.000116	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.2e-05	0.000115	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.84e-05	0.000111	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.76e-05	0.00011	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	8.57e-05	0.000107	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	8.51e-05	0.000107	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.25e-05	0.000103	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.01e-05	0.0001	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.99e-05	0.0001	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.96e-05	9.98e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.89e-05	9.89e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	7.65e-05	9.59e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	7.59e-05	9.52e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.59e-05	9.52e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.59e-05	9.52e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.47e-05	9.36e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.37e-05	9.23e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	7.04e-05	8.82e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.99e-05	8.76e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	6.97e-05	8.74e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.94e-05	8.7e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	6.93e-05	8.68e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.72e-05	8.42e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.28e-05	7.87e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.07e-05	7.61e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.01e-05	7.54e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.78e-05	7.24e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	5.05e-05	6.32e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.6e-05	5.77e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.57e-05	5.73e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	4.34e-05	5.44e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	4.25e-05	5.33e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.25e-05	5.32e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.23e-05	5.31e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.22e-05	5.29e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.18e-05	5.24e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	3.67e-05	4.61e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	3.28e-05	4.11e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.02e-05	3.78e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.99e-05	3.75e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.97e-05	2.47e-05	CbGpPWpGaD
